期刊文献+

氯诺昔康复合吗啡镇痛对肺切除患者术后呼吸功能的影响 被引量:4

Effects of analgesia with lornoxicam combined morphine on respiratory function in patients after pulmonary lobectomy
下载PDF
导出
摘要 目的观察氯诺昔康复合吗啡自控镇痛(PCA)对肺叶切除术患者呼吸功能的影响。方法 40例肺叶切除术患者随机分为氯诺昔康组(L组)和吗啡组(M组),每组20例。PCA泵的镇痛药为吗啡1 mg/ml;同时,L组于术毕和术后12、243、6 h静脉注射氯诺昔康,每次8 mg;M组在相应时点注射生理盐水,记录镇痛12、24、36和48 h VAS评分及镇静程度评分;PCA需求按压次数、有效按压次数及药物用量;术后各种并发症及不良反应发生率;术后24、48和72 h呼吸功能指标。结果两组患者各时点安静痛和咳嗽痛VAS评分差异无统计学意义;镇静程度评分、PCA需求按压次数、有效按压次数及药物用量L组显著低于M组(P<0.05);L组恶心发生率显著低于M组(P<0.05);L组术后244、8 h的用力肺活量(FVC)、第1秒用力肺活量(FEV1)和FEV1/FVC明显高于M组(P<0.05),PaCO2明显低于M组(P<0.05)。结论氯诺昔康用于肺叶切除术患者PCA可减少吗啡用量,并有利于呼吸功能恢复。 Objective To investigate effects of analgesia with lornoxicam combined morphine on patient controlled analgesia(PCA) and pulmonary function in patients after pulmonary lobectomy. Methods Forty patients were randomly allocated to two groups of lornoxicam (group L) and morphine(group M) with 20 cases each. Both groups received PCA with morphine 1 mg/ml. Group L was given intravenous lornoxicam 8 mg at 0, 12, 24 and 48 h during analgesia. VAS pain score, sedation score, demanded delivery, effective delivery, drug dose, and side effects were recorded at 12, 24,36 and 48 hours during analgesia. The parameters of pulmonary function were measured at 24,48 and 72 h after operation as well. Results There were no significant difference in VAS pain scores during analgesia between two groups. Sedation score, demanded delivery, effective delivery and drug dose were obviously lower in group L than those in group M(P〈0. 05). The incidence rate of nausea in group L was obviously lower than that in group M(P〈0.05). FVC, FEV1 and FEV1/FVC at 24 and 48 h after operation were significantly higher in group L than those in group M(P〈0. 05). PaCO2 at 24 and 48 h after operation was significantly lower in group L than that in group M(P〈0.05). Conclusion Lornoxicam can reduce morphine consumption and improve respiratory function during PCA with morphine in the patients after pulmonary lobectomy.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2010年第4期295-297,共3页 Journal of Clinical Anesthesiology
关键词 氯诺昔康 吗啡 镇痛 肺切除术 Lornoxicam Morphine Analgesia Pulmonary lobectomy
  • 相关文献

参考文献6

二级参考文献48

  • 1[1]Lichtenstein D, Syngal S, Wlfe MM. Non-steroidal antiinflammatory drugs and the gastrointestinal tract. Arthritis Rherm,1995;38:1:5~18.
  • 2[2]Bjarnason I, Macpherson A, Somasundaram S, et al. Lower bowel toxicity of non-steroidal anti-inflammatory drugs. Lewis A: Non-steroidal Anti-Inflammatory Drugs, Mechanisms and Clinical Uses. New York: NY, Marcel Dekker, 1994;145~157.
  • 3[3]Marie R, Griffin, MD. Epidemiology of non-steroidal antiinflammatory drug-associated gastrointestinal injury. Am J Med.1998;104: 23~28.
  • 4[4]Fujiwara Y, Schmassman A, Arakawa T, et al. Indomethacin interferes with epidermal growth factor binding and proliferative response of KATO Ⅲ cells. Digestion, 1995;56:364~369.
  • 5[5]Henry D, Robertson J. Non-steroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales.Gastroenterology. 1993; 104:1083~ 1091.
  • 6[6]Fries JF, Williams CA, Michel BA et al. Nonsteroidal antiinflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med, 1991 ;91:213 ~222.
  • 7[7]Gutthamm SP, García LA, Raiford DS. Individual nonsteroidal anti-inflammatory drugs and the risk of hospitalization for upper gastrointestinal bleeding and perforation in saskatche wan: a nested case-control study. Pharmacoepidemiol Drug Safety. 1994;3:S63.
  • 8[8]Loeb DS, Talley NJ, Ahlquist DA, et al. Long-term non-steroidal anti-inflammatorydrug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology, 1992;102 :1899~1905.
  • 9[9]Langman MJS, Weil J, Wainwright P, et al. Risk of bleeding peptic ulcer associated with individual non-steroidal antiinflammatory drugs. Lancet, 1994 ;34 3 :107 5-107 8
  • 10[10]Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications. am J Med, 1999;106:13~23.

共引文献114

同被引文献15

  • 1Mccormack K. Non-steroidal anti-inflammatory drugs and spi- nal nociceptive processing. Pain, 1994, 59.. 9-43.
  • 2Viscusi ER, GimbeI JS, Halder AM, et al. A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty. Anesth Analg, 2008, 107 (2) ,652-660.
  • 3Ott E, Nussmeier NA, Duke PC, et al. Efficacy and safety of the eyelooxygenase 2 inhibitors pareeoxib and valdecoxib in pa- tients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg, 2003,125(6) : 1481-1492.
  • 4Mussi RK,Camargo EA,Ferreira T. Exercise training reduces pulmonary ischemia-reperfusion-induced inflammatory response[J].European Respiratory Journal,2008,(03):645-649.
  • 5Esme H,Kesli R,Apiliogullari B. Effects of flurbiprofen on CRP,TNF-α,IL-6,and postoperative pain of thoracotomy[J].International Journal of Medical Sciences,2011,(03):216-221.
  • 6Mori T,Miyamoto T,Yoshida H. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis[J].International Immunology,2011,(11):701-712.
  • 7Pandazi A,Kapota E,Matsota P. Preincisional versus postincisional administration of parecoxib in colorectal surgery:effect on postoperative pain control and cytokine response.A randomized clinical trial[J].World Journal of Surgery,2010,(10):2463-2469.
  • 8Esme H Kesli R,Apiliogullari B. Effects of flurbiprofen on CRP,TNF-ā,IL-6,and postoperative pain of thoracotomy[J].International Journal of Medical Sciences,2011,(03):216-221.
  • 9Mori T,Miyamoto T,Yoshida H. IL-1 and TNFā-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis[J].International Immunology,2011,(11):701-712.
  • 10Ng A,Smith G,Davidson AC. Analgesic effects of parecoxib following total abdominal hysterectomy[J].British Journal of Anaesthesia,2003,(06):746-749.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部